Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
FDRH reports occasional consultancy fees from BMS, Pfizer, Novartis, Bayer, and Boehringer Ingelheim, unrelated to this Correspondence. BRS reports grant money paid to their employer (Berry Consultants) from the University of Oxford, for the sponsor's grant from the Medical Research Council, per the statistical design and analyses for the PRINCIPLE trial. MB reports grants from AstraZeneca and Roche; university honoraria from AstraZeneca, GSK, Cipla, and Boehringer Ingelheim; participation on data safety monitoring board or advisory board for AstraZeneca; and he is a scientific adviser to AstraZeneca's eosinophil strategy board, ProAxsis, and AlbusHealth. L-MY and CCB declare no competing interests.